News

ChemGenex submits NDA for leukemia treament

BY Alaric DeArment

MELBOURNE, Australia An Australian drug maker has submitted its approval application to the Food and Drug Administration for a new drug to treat leukemia.

ChemGenex announced the submission of the application for Omapro (omacetaxine mepesuccinate), designed to treat chronic myeloid leukemia in patients for whom Novartis’ Gleevec (imatinib), a first-line treatment for CML, has not worked and who have a gene mutation called T315I.

Omapro, the first drug of its class, has received orphan drug designation from the FDA. The FDA grants the designation to investigational drugs that treat rare diseases or diseases for which no adequate treatments exist, giving them certain advantages in the drug approval process such as fast-track review and longer market exclusivity periods.

“If approved, Omapro would be the first treatment specifically indicated for CML T315I patients, many of whom have no therapeutic options,” ChemGenex SVP and chief medical officer Adam Craig said in a statement.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

A&P program offers online pharmacy services

BY Antoinette Alexander

MONTVALE, N.J. A&P announced on Tuesday that its Live Better! Wellness program now provides online pharmacy services.

“We are proud to introduce this innovative new benefit, which will make filling prescriptions more convenient than ever before. It is just another way we are helping our customers maintain their health by offering improved access to prescription drugs,” stated Carol DiNicolantonio, senior director of pharmacy for A&P.

Prescriptions are processed, filled and distributed from this “home delivery only” pharmacy located in Old Tappan, N.J.

The Live Better! Pharmacy provides such services as prescriptions filled by pharmacists, access to pharmacists seven days a week, easy prescription transfers and prescriptions delivered to the patient?s door.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Annual GMDC conference highlights future of health, beauty and wellness initiatives

BY Allison Cerra

COLORADO SPRINGS, Colo. The Global Market Development Center is kicking off its 39th annual Health Beauty Wellness Marketing Conference this week in Orlando, Fla., extensively focusing on the health, beauty and wellness initiatives across the entire retail store.

GMDC has invited and colocated the conference with the Food Marketing Institute Supermarket Pharmacy Conference. The two conferences offer members of both associations an opportunity to develop strategies and tactics to capitalize on the emerging health and wellness opportunities at retail.

GMDC and FMI members have the opportunity to participate in sessions where retailers, suppliers and service companies will meet to discuss strategic initiatives across all departments of retail and wholesale members.

Additionally, the conference will feature roundtable discussions, focusing on the future of health, beauty and wellness along with the industry’s emerging topics and issues.

“We have created a meeting agenda that maintains the identities of the two individual events while creating a forum for collaborative business meetings and education. In Orlando this week, supplier and service companies are joining executives from the health, wellness, beauty, pharmacy and center store departments of wholesale and retail members to work together on developing the categories essential for presenting a health and wellness shopping experience that meets the needs of today’s consumer”, said David McConnell, GMDC president and CEO.

For more information regarding the GMDC Health Beauty Wellness Marketing Conference, please visit www.gmdc.org.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?